- Fish oil (omega-3 fatty acids, primarily EPA and DHA) has a plausible biological link to sleep, but the human clinical evidence is modest and inconsistent.
- The most compelling trial found that DHA supplementation improved sleep duration and reduced night waking in children; adult data are far thinner.
- Fish oil is generally safe for most adults at doses up to 2–3 g/day of combined EPA+DHA, but it is not a proven sleep aid and should not replace good sleep-hygiene practices.
- People on blood thinners, those with fish allergies, or those who are pregnant should speak to a clinician before supplementing.
What the evidence shows
The honest summary: the evidence that fish oil meaningfully improves sleep quality in healthy adults is weak. There are plausible biological reasons to think omega-3s matter for sleep (more on that below), and a handful of studies show positive signals, but the overall picture is far from settled.
The most-cited human trial is a randomized, double-blind study by Montgomery and colleagues involving 362 school-age children in the UK. Compared to placebo, children taking 600 mg/day of DHA for 16 weeks slept about 58 minutes longer per night and woke approximately seven fewer times per week, as measured by actigraphy (Montgomery et al., 2014). That is a notable effect — but children are not adults, the dose was DHA-only, and the children were selected partly because of reading difficulties (which correlates with omega-3 status), so the result may not generalize.
In adults, the picture is murkier. A 2021 systematic review of omega-3 supplementation and sleep found some positive associations between higher omega-3 status and better self-reported sleep quality, but the controlled trial evidence in adult populations was limited and inconsistent in design, dose, and outcome measures (Aulinas et al., 2021). One small crossover trial found that a high-seafood diet (a proxy for omega-3 intake) was associated with faster sleep onset and higher heart rate variability during sleep, though the intervention was dietary rather than supplemental (Hansen et al., 2014).
Importantly, most studies that show any effect measure sleep as a secondary outcome — fish oil was the main intervention for something else (cardiovascular health, inflammation, mood), and sleep was tracked along the way. That kind of secondary-outcome evidence is lower quality than a trial designed from the start to test sleep.
Bottom line on the evidence: if you have a confirmed omega-3 deficiency or eat little fatty fish, correcting that gap may support sleep among other health outcomes. But taking fish oil capsules specifically to cure poor sleep is not supported by the current clinical literature.
How it works (mechanism)
There are at least two credible biological pathways connecting omega-3 fatty acids and sleep:
- Melatonin synthesis: DHA is incorporated into the pineal gland membranes, and animal studies suggest it plays a role in regulating melatonin production — the hormone most directly linked to sleep timing. Lower DHA status has been associated with lower melatonin output in some animal models (Lavialle et al., 2008).
- Serotonin modulation: EPA and DHA influence the production, release, and receptor sensitivity of serotonin, a neurotransmitter that is a precursor to melatonin and plays a role in regulating the sleep-wake cycle (Patrick & Ames, 2015).
- Anti-inflammatory effects: Chronic low-grade inflammation is increasingly linked to disrupted sleep architecture. Omega-3s are well-established anti-inflammatory agents (Calder, 2013), so theoretically reducing inflammatory load could improve sleep — though this chain of reasoning has not been definitively demonstrated in sleep-focused trials.
These mechanisms are biologically plausible but have mostly been demonstrated in cell studies or animal models. Plausibility is not the same as proof in humans.
Dose & timing if you try it
If you eat little oily fish and want to trial fish oil with realistic expectations, here is what the better-conducted studies suggest:
- Dose: 600 mg–1,000 mg of DHA per day was the range used in the positive pediatric trial. Most adult cardiovascular guidelines suggest 1,000–2,000 mg of combined EPA+DHA daily; doses up to 3,000 mg are generally considered safe by the FDA (as GRAS). Higher doses increase bleeding risk.
- Timing: No strong evidence specifies an ideal time of day for sleep benefit. Taking fish oil with the largest meal of the day improves absorption and reduces the "fishy burp" side effect.
- Duration: The Montgomery et al. trial ran 16 weeks. It is reasonable to trial any supplement for at least 8–12 weeks before evaluating effect.
- Form: Look for triglyceride-form fish oil (versus ethyl ester), which absorbs better with food. Check that the product has third-party testing for mercury and PCBs (NSF, USP, or IFOS certification).
Do not use fish oil as a substitute for addressing underlying sleep disorders such as insomnia or sleep apnea — those require clinical evaluation.
Who should skip
- People taking anticoagulants or antiplatelet drugs (warfarin, clopidogrel, aspirin therapy): omega-3s have blood-thinning properties; combining them can increase bleeding risk.
- People with fish or shellfish allergies: most fish oil products are derived from anchovy, sardine, or mackerel — allergic reactions are possible. Algal-oil DHA (vegan source) is an alternative.
- People with uncontrolled atrial fibrillation: very high-dose prescription omega-3s (4 g/day, e.g., icosapentaenoic acid formulations) have been associated with increased AF risk in some trials.
- Pregnant individuals: omega-3s are generally considered beneficial in pregnancy for fetal brain development, but dose and source matter — high-mercury fish should be avoided, and any supplementation should be discussed with an OB or midwife.
- People scheduled for surgery: omega-3 supplementation is typically paused 1–2 weeks before elective procedures due to platelet effects.
Bottom line
Fish oil is not a proven sleep aid. The mechanistic logic is reasonable, one well-designed trial in children is encouraging, and higher omega-3 status is associated with modestly better sleep in observational data — but controlled adult trials that set out specifically to test sleep as the primary outcome are largely absent. If you eat little oily fish and are already considering fish oil for heart or joint health, better sleep might be a secondary benefit worth tracking. But buying fish oil primarily to fix poor sleep is getting ahead of the evidence. Cognitive behavioral therapy for insomnia (CBT-I) and consistent sleep-hygiene practices have far stronger evidence behind them and should come first.
References
- Calder, P. C. (2013). Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? British Journal of Clinical Pharmacology, 75(3), 645–662.
- Hansen, A. L., et al. (2014). Fish consumption, sleep, daily functioning, and heart rate variability. Journal of Clinical Sleep Medicine, 10(5), 567–575.
- Lavialle, M., et al. (2008). An ω-3 fatty acid-deficient diet disturbs daily locomotor activity, melatonin rhythm, and striatal dopamine in Syrian hamsters. Journal of Nutritional Biochemistry, 19(7), 452–461.
- Montgomery, P., et al. (2014). Fatty acids and sleep in UK children: Subjective and pilot objective sleep results from the DOLAB study. Journal of Sleep Research, 23(4), 364–388.
- Patrick, R. P., & Ames, B. N. (2015). Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2. FASEB Journal, 29(6), 2207–2222.
- Aulinas, A., et al. (2021). Omega-3 fatty acids and sleep: A systematic review. Note: Limited high-quality randomized controlled trial evidence in adult populations as of this review's publication.